ImmunoGen, Inc.

ImmunoGen, Inc.verified

IMGN

Price:

$31.235

Market Cap:

$8.73B

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeut...[Read more]

Industry

Biotechnology

IPO Date

1989-11-17

Stock Exchange

NASDAQ

Ticker

IMGN

The Dividend Yield as of December 2024 (TTM) for ImmunoGen, Inc. (IMGN) is 0%

According to ImmunoGen, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

ImmunoGen, Inc. (IMGN) Historical Dividend Yield (quarterly & annually)

How has IMGN Dividend Yield performed in the past?

The mean historical Dividend Yield of ImmunoGen, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), IMGN's Dividend Yield was at its highest in in the December 2013 quarter at 0%. The Dividend Yield was at its lowest in in the December 2013 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

ImmunoGen, Inc. (IMGN) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of ImmunoGen, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20160%0%
20150%0%
20140%0%

ImmunoGen, Inc. (IMGN) Average Dividend Yield

How has IMGN Dividend Yield performed in the past?

The current Dividend Yield of ImmunoGen, Inc. (IMGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

ImmunoGen, Inc. (IMGN) Dividend Yield vs. Peers

How is IMGN’s Dividend Yield compared to its peers?

ImmunoGen, Inc.’s Dividend Yield is less than Madrigal Pharmaceuticals, Inc. (0%), less than Intercept Pharmaceuticals, Inc. (0%), less than TG Therapeutics, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Hepion Pharmaceuticals, Inc. (0%), less than Viking Therapeutics, Inc. (0%), less than Axsome Therapeutics, Inc. (0%), less than Seres Therapeutics, Inc. (0%), less than Mereo BioPharma Group plc (0%), less than PDS Biotechnology Corporation (0%), less than Inozyme Pharma, Inc. (0%), less than HOOKIPA Pharma Inc. (0%), less than eFFECTOR Therapeutics, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Elevation Oncology, Inc. (0%), less than Akero Therapeutics, Inc. (0%), less than Reata Pharmaceuticals, Inc. (0%),

Build a custom stock screener for ImmunoGen, Inc. (IMGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunoGen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmunoGen, Inc. (IMGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmunoGen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is ImmunoGen, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for ImmunoGen, Inc. (IMGN)?

What is the highest Dividend Yield for ImmunoGen, Inc. (IMGN)?

What is the 3-year average Dividend Yield for ImmunoGen, Inc. (IMGN)?

What is the 5-year average Dividend Yield for ImmunoGen, Inc. (IMGN)?

How does the current Dividend Yield for ImmunoGen, Inc. (IMGN) compare to its historical average?